Design decisions that hold up under scrutiny.

UX strategy, experience design & AI product strategy for regulated healthcare and pharma brands.

Open to UX Director and Senior Strategy roles

From brief to reframed problem

Abbott · FreeStyle Libre

Client brief

“Improve the onboarding communications program — patients aren't engaging with the content we're sending them during device activation.”

Reframed UX problem

This isn't a content engagement problem — it's a sequencing alignment failure.

The content was correct. The timing was wrong.

Eli Lilly · Global Obesity

Client brief

“Design a global obesity platform that can be adapted for each market — KSA, UAE, Germany, Japan — while maintaining brand and regulatory consistency.”

Reframed UX problem

The brief frames this as an adaptation problem. It's actually two problems.

Global architecture plus stigma-aware emotional sequencing, not localization of a standard pharma UX template.

4 markets, one IA frameworkRead the Eli Lilly case study

Amgen · Enbrel

Client brief

“The redesigned site is underperforming — users can’t find what they need. Fix the navigation and improve content findability.”

Reframed UX problem

This isn’t a navigation problem — it’s a dual-audience architecture failure.

Prospective and current patients are different users. The redesign treated them as one.

Amgen · Enbrel CRM

Client brief

“Unique open rate is strong — we need to improve CTR.”

Reframed UX problem

This isn’t a single CTR problem — it’s two structurally different problems by email type.

Actionable emails failed at scan and engage. Informational emails had no primary CTA by design.

Featured work

View all work

From diagnosis to delivery.

Most engagements don't fail in the design. They fail upstream, in a brief nobody questioned, or downstream, in a review room that stalls.

01
Diagnose
Most briefs arrive as a content problem or a design problem. Half the time it's neither — the real issue is a sequencing gap or an assumption nobody's tested. This is where I find out which one I'm actually solving.
Brief cleared internally
02
Audit
Before a wireframe gets drawn, I want to know what's already broken and what competitors have already tried. AI-augmented competitive intelligence gets me there fast now — but someone still has to know which pattern actually matters.
Findings pass heuristic review
03
Align
This is where most projects stall — not in the design, but in getting Legal, Medical, and Brand to agree on what shipped. I build the journey architecture and IA to survive that room the first time, not the third.
MLR sign-off
04
Scale
A framework that only works in one market isn't a framework — it's a one-off. I build IA that deploys across regulatory environments without a rebuild, because that's the part that actually compounds.

Results, by engagement.

↓ 20% drop-off
Patient onboarding · FreeStyle Libre
View case study: Abbott
89%
Bounce rate after the 2021 redesign, up from 63% · Enbrel
View case study: Amgen Enbrel
4 markets
One IA framework, deployed without a rebuild · Global Obesity
View case study: Eli Lilly

The thinking behind the work.

View all writing
The Slop Tax
LinkedIn Article · AI & Design Judgment

The Slop Tax

“Every brand can generate content now. That's exactly the problem.”

AI removed the production bottleneck that used to hide how much of good work was always judgment. What's left exposed is a harder question: do you actually know what "good" means for the person you're designing for?

Read on LinkedIn ↗
The Job Description Doesn't Exist Yet
LinkedIn Article · AI Governance & Org Design

The Job Description Doesn't Exist Yet

“Adoption outran governance. Governance just outran the org chart.”

Companies are hiring an AI Governance Specialist and an AI Product Manager for what's functionally one job. That split isn't a hiring quirk — it's a structural flaw, and regulated industries are already paying to fix it.

Read on LinkedIn ↗

Open to the right conversation.

Director, Lead, and Head of UX Strategy, Experience Design & AI Product Strategy roles in healthcare, pharma, health tech, and regulated enterprise. Agency or in-house · Full-time or freelance/fractional. New York City Metropolitan Area · Remote · Hybrid.

Get in touch